Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.
Open Orphan plc (LON:ORPH), (to be renamed hVIVO plc (LON:HVO) effective 26 October 2022), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory..
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF, a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, announces that further to the Option Agreement announced in December..
N4 Pharma plc (LON:N4P) CEO Nigel Theobald chats to DirectorsTalk Interviews about its development plans for commercialising Nuvec. Nigel talks us through the update highlights, explains why companies working with..
Poolbeg Pharma (LON:POLB) CEO Jeremy Skillington joins DirectorsTalk Interviews to discuss interim results for the six months to 30th June 2022. Jeremy talks us through the financial and operational highlights,..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, today announced its unaudited interim results for the six months to..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £2.2 million contract providing cognitive assessments and electronic..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has today announced..
Goodbody Health Inc. (AQSE: GDBY) has announced its half year 2022 unaudited Interim Financial Statements for the six months to 30 June 2022. The revenue at £7.40m was £2.55m higher..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced that NXP002, a new form of tranilast and a potential..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, today announced that..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced two agreements in a new therapeutic area for the Company, post-traumatic stress disorder..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced strong growth for the six months ended 30 June 2022. The unaudited financial..
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, announced today that it has received ethics and competent authority..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced a further update on its recent pre-clinical study with..
Cizzle Biotechnology plc (LON:CIZ), the UK based diagnostics developer, has today provided an update on the Company’s progress to develop antibodies for use in its proprietary early lung cancer tests,..
Vaxart becomes the first client of the programme to test its oral COVID-19 vaccine candidate Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world..
Goodbody Health Inc. (AQSE:GDBY) Executive Chairman Geremy Thomas joins DirectorsTalk Interviews to discuss its intention to de-list from the Canadian Securities Exchange and to re-domicile the Company from the Province..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that..
